Contact French BioBeach for event and ticket information.
Monday, December 07, 2009 from 6:00 PM - 9:00 PM (PT)
&
Would like to invite you to join us on
Monday December 7th 6:00PM - 9:00 PM
Biotech Conference & Business Mixer
"A Window into Lyon Life Science Companies"
''Lyonbiopole'', the French center of excellence
in vaccines and diagnostics, is coming to the San Diego Area. Meet French life
sciences executives from Lyon, the capital of immunology and bioproduction in France and Europe
and learn about their innovative approaches to immunomonitoring, vaccine
therapy and biomanufacturing. Imaxio is a biopharmaceutical company
specializing in oncology and infectious diseases, for which the company
develops and commercializes diagnostic and therapeutic products. ImmunID offers
innovative immunomonitoring & diagnostic solutions
to characterize immune dysfunction and analyzes the impact of immunotherapy on
Immune Repertoire. PX Therapeutics provides integrated bio therapeutics and recombinant vaccines
development and manufacturing contract services. Join us for an evening
of unique insights into 3 French life sciences companies.
Program:
- 6:00 - 6:30 PM - Guest registration
- 6:30 - 6:35 - Welcoming by Stephane Richard, Founder of French BIO Beach
- 6:35 - 7:20 - Integrated Solutions for immunotherapy Development: Case Studies from Lyon
Moderator
Xavier Frapaise, CSO, Optimer Pharmaceuticals
Panel
FrançoisMiceli, CEO, Imaxio (Vaccinotherapy)
Nicolas Pasqual, CEO and co-founder, ImmunID Technologies (Immunomonitoring)
Christelle Dagoneau, Business Development Director, PX Therapeutics (Biomanufacturing)
-7:30 - 9:00 - Concluding Remarks and Cocktail opening
If you wish to attend to this event, please don’t forget to register online.
This event is hosted by French BIO Beach and
highly supported by the LyonBioPole, the ADERLY and the Invest
in France Agency.
Xavier Frapaise, CSO, Optimer Pharmaceuticals
Academic position : Loyola University Medical Center/ Thrombosis Research Center, Maywood IL
Currently Sr. VP and Chief Scientific Officer at Optimer Pharmaceuticals, San Diego, a company in late stage development of 2 new anti-bacterials
31 yrs of drug development experience in Europe and USA, at “big Pharma” (Sanofi, Bayer, Abbott) and San Diego-based biotech companies (Ocera, Asphelia).
François Miceli, CEO, Imaxio
Imaxio is a
biopharmaceutical company specializing in the fields of oncology and
infectious diseases, for which the company develops and commercializes
diagnostic and therapeutic products. As for example, company markets
throughout France a vaccine against leptospirosis. In collaboration with
the University of Oxford, through a Grand Challenges in Global Health grant
to the Jenner Institute, novel viral vector vaccines against neglected
diseases are being developed which incorporate Imaxio's proprietary aXentTM
adjuvant. (Industrial partnership agreements have also been signed for the
adjuvant).
Nicolas Pasqual,
CEO and co-founder,
ImmunID
Technologies
Thanks to
its original concept of
"Immune Weather Forecast"
ImmunID offers innovative immunomonitoring
& diagnostic solutions to characterize immune
dysfunction and analyse the impact of immunotherapy on Immune Repertoire.
ImmunID solutions are used from
research
to clinical validation to measure efficacy and toxicity risk of molecules
such as Monoclonal antibodies (anti-CD20...), Interleukins (IL2, IL7...),
or vaccines (prophylactic or therapeutic). ImmunID solutions are used to
diagnose certain pathologies
such as Lymphoma and Leukemia, and to monitor immunodeficiency and follow
up disease progression and immunomodulators efficacy. Pathologies mainly
concerned are blood cancers, infectious diseases, cancers, autoimmune
diseases.
Christelle Dagoneau,
Business Development Director,
PX
Therapeutics
The company
provides integrated bio therapeutics and recombinant vaccines development
and manufacturing contract services. They are organized around three
integrated service platforms : recombinant protein R&D, monoclonal antibody
development and cGMP manufacturing. ). They gained substantial experience
in the production of challenging proteins and developed trusted
relationships with more than 140 pharmaceutical, biotech and academic
partners worldwide, as for example : Merial, Sanofi Pasteur, Biomérieux,
BD, Tibotec, GSK, Pfizer, Galderma, Stallergenes, etc.
French BioBeach Partners & Sponsors:
French BioBeach is a San Diego based networking organization for US and French biotech communities.
You can visit www.frenchbiobeach.com, attend our events and contact us for personalized services (BtoB).
Become a French BioBeach member to access additional resources, participate to our discussion forum and benefit from the French BioBeach Privilege Card.
French BioBeach initiative started in
South California in 2006 as a combined effort of the Economic Department of the French Embassy & GEN2X LLC.
Today services are available in San Francisco
and Seattle with French Bio Bay and French Bio Sea and we are currently
working on our expansion in Boston.
www.frenchbiobeach.com
 |
View other French BioBeach events |
 |
Contact the Host |
 |
Subscribe to receive notifications of future events by this host |
Email
Facebook
Twitter
LinkedIn
MySpace
Digg
Delicious
Reddit